Expert consensus on evaluation index system construction for new traditional Chinese medicine(TCM) from TCM clinical practice in medical institutions.
10.19540/j.cnki.cjcmm.20250325.602
- Author:
Li LIU
1
;
Lei ZHANG
2
;
Wei-An YUAN
3
;
Zhong-Qi YANG
4
;
Jun-Hua ZHANG
5
;
Bao-He WANG
6
;
Si-Yuan HU
6
;
Zu-Guang YE
7
;
Ling HAN
8
;
Yue-Hua ZHOU
8
;
Zi-Feng YANG
9
;
Rui GAO
10
;
Ming YANG
11
;
Ting WANG
12
;
Jie-Lai XIA
13
;
Shi-Shan YU
14
;
Xiao-Hui FAN
15
;
Hua HUA
16
;
Jia HE
17
;
Yin LU
18
;
Zhong WANG
19
;
Jin-Hui DOU
20
;
Geng LI
7
;
Yu DONG
21
;
Hao YU
22
;
Li-Ping QU
23
;
Jian-Yuan TANG
1
Author Information
1. Hospital of Chengdu University of Traditional Chinese Medicine Chengdu 610075, China.
2. Shanghai University of Traditional Chinese Medicine Shanghai 201203, China.
3. Shuguang Hospital of Shanghai University of Traditional Chinese Medicine Shanghai 200021, China.
4. the First Affiliated Hospital of Guangzhou University of Chinese Medicine Guangzhou 510405, China.
5. Tianjin University of Traditional Chinese Medicine Tianjin 301617, China.
6. the First Affiliated Hospital of Tianjin University of Traditional Chinese Medicine Tianjin 300193, China.
7. Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences Beijing 100700, China.
8. Center for Drug Evaluation, National Medical Products Administration Beijing 100022, China.
9. State Key Laboratory of Respiratory Diseases, Guangzhou Medical University Guangzhou 510180, China.
10. Xiyuan Hospital, China Academy of Chinese Medical Sciences Beijing 100091, China.
11. Jiangxi University of Chinese Medicine Nanchang 330004, China.
12. Beijing University of Chinese Medicine Beijing 100105, China.
13. Air Force Medical University Xi'an 710032, China.
14. State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College Beijing 100050, China.
15. Innovation Center of Yangtze River Delta, Zhejiang University Jiaxing 314102, China.
16. Sichuan Translational Medicine Centre of Traditional Chinese Medicine Chengdu 610041,China.
17. Naval Medical University Shanghai 200433, China.
18. School of Pharmacy, Nanjing University of Chinese Medicine Nanjing 210023, China.
19. Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences Beijing 100700, China.
20. Shanghai Zhimeng Biopharma,Inc Shanghai 200433, China.
21. Guang'anmen Hospital, China Academy of Chinese Medical Sciences Beijing 100053, China.
22. Nanjing Medical University Nanjing 211166, China.
23. Chengdu University of Traditional Chinese Medicine Chengdu 611137, China.
- Publication Type:Consensus Development Conference
- Keywords:
evaluation;
expert consensus;
index system;
medical institution;
new traditional Chinese medicine drugs;
traditional Chinese medicine clinical practice;
transformation
- MeSH:
Medicine, Chinese Traditional/standards*;
Humans;
Consensus;
Drugs, Chinese Herbal/therapeutic use*;
Surveys and Questionnaires
- From:
China Journal of Chinese Materia Medica
2025;50(12):3474-3482
- CountryChina
- Language:Chinese
-
Abstract:
Medical institutions, with their clinical practice foundation and abundant human use experience data, have become important carriers for the inheritance and innovation of traditional Chinese medicine(TCM) and the "cradles" of the preparation of new TCM. To effectively promote the transformation of new TCM originating from the TCM clinical practice in medical institutions and establish an effective evaluation index system for the transformation of new TCM conforming to the characteristics of TCM, consensus experts adopted the literature research, questionnaire survey, Delphi method, etc. By focusing on the policy and technical evaluation of new TCM originating from the TCM clinical practice in medical institutions, a comprehensive evaluation from the dimensions of drug safety, efficacy, feasibility, and characteristic advantages was conducted, thus forming a comprehensive evaluation system with four primary indicators and 37 secondary indicators. The expert consensus reached aims to encourage medical institutions at all levels to continuously improve the high-quality research and development and transformation of new TCM originating from the TCM clinical practice in medical institutions and targeted at clinical needs, so as to provide a decision-making basis for the preparation, selection, cultivation, and transformation of new TCM for medical institutions, improve the development efficiency of new TCM, and precisely respond to the public medication needs.
